Research subjects with non-alcoholic fatty liver disease which has had very few viable treatment options so far enjoyed a really dramatic drop in liver fat
After 11 months and 52 pounds lost, I had my body composition tested
During the last 2 weeks of the titration periods in those 12 participants, semaglutide led to a higher time in range by 4.3 percentage points (5.5, P = 0.02), lower insulin usage by 12.2 U [16.2, 5.4] ( P = 0.008) and lower carbohydrate intake by 50 g (35
This new research will complement a new American Heart Association scientific statement, published in Circulation , highlighting the importance of identifying and treating people at increased risk for heart failure before symptoms develop
These treatments work by curbing appetite and improving metabolic function, making it easier to lose weight and keep it off